Table 4.
Live vaccine schedule for inflammatory bowel disease patientsa,b
| Vaccine (brand names) | Target group | Dosing scheduleb | Comments |
|---|---|---|---|
| Mumps, measles, rubella (M-M-R) | If vaccination history unknown | Two doses 0.5 mL IM at least 4 weeks apart | Contraindicated in patients on immunosuppression |
| Varicella (Zuvicella) | If vaccination history unknown | Two doses 0.5 mL SC at least 4 weeks apart | Contraindicated in patients on immunosuppression |
| Herpes zoster (Zostavax) | Patients age > 50 years with unknown vaccination history irrespective of previous exposure | Single dose of 0.65 mL SC | Patients on low-level immunosuppression may be vaccinated |
IM intramuscular, SC subcutaneous
aLive vaccines should be administered in IBD patients 4–6 weeks before initiating immunosuppressive therapy
bDose of vaccine may vary. Please refer to the product monograph before administration